| Literature DB >> 34952901 |
Nutnicha Neti1, Pinnita Prabhasawat2, Chareenun Chirapapaisan1, Panotsom Ngowyutagon1.
Abstract
To assess the impact of COVID-19 lockdown measures on dry-eye symptoms in a community-based population, a cross-sectional study was conducted during the first wave of the COVID-19 outbreak in Thailand. An online survey was distributed via social media between June and July 2020. The questionnaire elicited information on demographics, dry-eye symptoms, use of visual display terminals, and mental health status. There were 535 respondents. Thirty-seven percent reported having been diagnosed with dry-eye disease (DED). During the lockdown, the mean dry-eye symptom score (DESS) of overall participants dropped significantly from 81.6 ± 15.9 to 79.8 ± 17.4 (P < 0.001). The mean, daily, visual display terminal (VDT) usage increased from 10.55 ± 5.16 to 13.08 ± 5.65 h (P < 0.001). A negative correlation between age and VDT usage was observed in both the normal and lockdown situations. One-quarter of all participants had an abnormal mental health status. The female gender (OR 1.86; 95% CI 1.14-3.04) and increased VDT usage during the lockdown (OR 5.68; 95% CI 3.49-9.23) were independently associated with worsening dry-eye symptoms. The lockdown measures abruptly altered the behaviors and lifestyles of the overall population. Excessive exposure to VDTs were associated with deteriorated dry-eye symptoms, and it possibly contributed to the increased DED incidence in the surveyed population.Entities:
Mesh:
Year: 2021 PMID: 34952901 PMCID: PMC8709849 DOI: 10.1038/s41598-021-03887-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Distribution of ages of participants.
Figure 2Dry-eye symptom scores (DESS) of each age group for normal and COVID-19 lockdown situations.
Comparison of the mean dry-eye symptom scores of the dry-eye and non-dry-eye participants.
| Dry-eye symptom score | |||
|---|---|---|---|
| Normal situation | COVID-19 lockdown | ||
| Mean (SD) | Mean (SD) | ||
| Total | 74.10 (14.55) | 72.16 (15.98) | < 0.001* |
| Age ≤ 60 years | 74.16 (13.94) | 71.96 (15.21) | < 0.001* |
| Age > 60 years | 73.79 (17.73) | 73.21 (19.88) | 0.639 |
| Total | 86.00 (14.95) | 84.25 (16.70) | < 0.001* |
| Age ≤ 60 years | 85.9 (15.36) | 84.05 (17.18) | < 0.001* |
| Age > 60 years | 86.98 (10.15) | 86.23 (10.88) | 0.167 |
*P < 0.05; higher dry-eye symptom score indicates fewer dry-eye symptoms.
Visual display terminal usage of each age group during the normal and COVID-19 lockdown situations.
| Age range | VDT usage (h) | ||
|---|---|---|---|
| Normal situation | COVID-19 lockdown | ||
| Mean (SD) | Mean (SD) | ||
| Total | 11.03 (5.17) | 13.74 (5.50) | < 0.001* |
| 21–30 | 13.64 (4.59) | 15.92 (4.96) | < 0.001* |
| 31–40 | 12.29 (5.47) | 14.69 (5.60) | < 0.001* |
| 41–50 | 10.47 (5.03) | 13.78 (5.09) | < 0.001* |
| 51–60 | 9.61 (4.73) | 12.36 (5.43) | < 0.001* |
| Total | 6.84 (3.32) | 8.05 (4.15) | < 0.001* |
| 61–70 | 6.84 (3.08) | 8.15 (4.13) | < 0.001* |
| 71–80 | 6.71 (5.28) | 7.36 (4.87) | 0.001* |
*P < 0.05.
Figure 3The number of participants using long-time visual display terminals, by purpose, during the normal and COVID-19 lockdown situations.
Risk factors for abnormal Thai GHQ-12 score during the lockdown.
| Thai GHQ-12 score; n (%) | OR | 95% CI | |||
|---|---|---|---|---|---|
| Normal | Abnormal | ||||
| Age ≤ 60 years | 347 (87) | 126 (92) | 0.163 | 1.68 | (0.85–3.33) |
| Female | 264 (66) | 96 (70) | 0.461 | 1.19 | (0.78–1.81) |
| DED patients | 149 (37) | 50 (36) | 0.918 | 0.96 | (0.64–1.44) |
| DESS < 75 | 118 (30) | 61 (45) | 0.002* | 1.91 | (1.28–2.84) |
*P < 0.05; DED dry-eye disease, DESS dry-eye symptom score.
Univariate and multivariate analyses of risk factors that worsened dry-eye symptoms during the lockdown.
| Risk factors | DED symptoms worsened | DED symptoms not worsened | OR | 95% CI | |
|---|---|---|---|---|---|
| N (%) | N (%) | ||||
| Age ≤ 60 years | 130 (94.2) | 343 (86.4) | 0.02* | 2.56 | 1.19–5.52 |
| DED | 56 (40.6) | 143 (36.0) | 0.36 | 1.21 | 0.82–1.80 |
| Female | 108 (78.3) | 145 (36.5) | 0.001* | 2.07 | 1.32–3.26 |
| Increased VDT usage during the lockdown | 113 (81.9) | 163 (41.1) | < 0.001* | 6.49 | 4.03–10.46 |
| Ocular allergic disease | 22 (15.9) | 32 (8.1) | 0.01* | 2.16 | 1.21–3.87 |
| Glaucoma | 6 (4.3) | 11 (2.8) | 0.4 | 1.6 | 0.58–4.40 |
| Abnormal Thai GHQ-12 score | 49 (35.5) | 88 (22.2) | 0.002* | 1.93 | 1.27–2.95 |
| N = 56 | N = 143 | ||||
| Decreased frequency of artificial tear use during COVID-19 lockdown | 6 (10.7) | 20 (14.0) | 0.64 | 0.72 | 0.27–1.91 |
* P < 0.05; DED, dry-eye disease; VDT, visual display terminal.